XML 131 R102.htm IDEA: XBRL DOCUMENT v3.24.1
Share-Based Payments -Schedule of Number and Weighted-Average Exercise Price of Share Options Allocated and Expected to be Allocated (Details) - Management Board Grant
1 Months Ended 12 Months Ended
May 17, 2021
shares
€ / shares
May 12, 2021
shares
€ / shares
May 31, 2022
shares
Feb. 29, 2020
shares
€ / shares
Dec. 31, 2023
shares
€ / shares
May 30, 2022
shares
€ / shares
Disclosure of terms and conditions of share-based payment arrangement [line items]            
(Phantom) share options outstanding (expected to be allocated) (in shares) 6,463 45,279   248,096   86,118
thereof allocated and vested but subject to performance and waiting requirements (in shares) 3,232 22,640 21,531 186,072    
thereof allocated and un-vested (in shares) 3,231 22,639 64,587 62,024    
Weighted-average exercise price (in euros per share) | € / shares € 169.08 € 167.63   € 28.32   € 137.65
Allocation date May 2023            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
(Phantom) share options outstanding (expected to be allocated) (in shares)         130,586  
thereof allocated and un-vested (in shares)         130,586  
Weighted-average exercise price (in euros per share) | € / shares         € 105.42  
Estimated allocation date 2024            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
(Phantom) share options outstanding (expected to be allocated) (in shares)         164,148  
thereof allocated and un-vested (in shares)         0  
Weighted-average exercise price (in euros per share) | € / shares         € 96.82  
Estimated allocation date 2025            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
(Phantom) share options outstanding (expected to be allocated) (in shares)         118,312  
thereof allocated and un-vested (in shares)         0  
Weighted-average exercise price (in euros per share) | € / shares         € 99.74  
Estimated allocation date 2026            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
(Phantom) share options outstanding (expected to be allocated) (in shares)         93,561  
thereof allocated and un-vested (in shares)         0  
Weighted-average exercise price (in euros per share) | € / shares         € 105.13